2024-07-08Zeitschriftenartikel
Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)]
| dc.contributor.author | Laniece Delaunay, Charlotte | |
| dc.contributor.author | Melo, Aryse | |
| dc.contributor.author | Maurel, Marine | |
| dc.contributor.author | Mazagatos, Clara | |
| dc.contributor.author | Goerlitz, Luise | |
| dc.contributor.author | O'Donnell, Joan | |
| dc.contributor.author | Oroszi, Beatrix | |
| dc.contributor.author | Sève, Noémie | |
| dc.contributor.author | Rodrigues, Ana Paula | |
| dc.contributor.author | Martínez-Baz, Iván | |
| dc.contributor.author | Meijer, Adam | |
| dc.contributor.author | Mlinarić, Ivan | |
| dc.contributor.author | Latorre-Margalef, Neus | |
| dc.contributor.author | Lazăr, Mihaela | |
| dc.contributor.author | Pérez-Gimeno, Gloria | |
| dc.contributor.author | Dürrwald, Ralf | |
| dc.contributor.author | Bennett, Charlene | |
| dc.contributor.author | Túri, Gergő | |
| dc.contributor.author | Rameix-Welti, Marie-Anne | |
| dc.contributor.author | Guiomar, Raquel | |
| dc.contributor.author | Castilla, Jesús | |
| dc.contributor.author | Hooiveld, Mariëtte | |
| dc.contributor.author | Kurečić Filipović, Sanja | |
| dc.contributor.author | Samuelsson Hagey, Tove | |
| dc.contributor.author | Dijkstra, Frederika | |
| dc.contributor.author | Borges, Vitor | |
| dc.contributor.author | Ramos Martín, Violeta | |
| dc.contributor.author | Bacci, Sabrina | |
| dc.contributor.author | Kaczmarek, Marlena | |
| dc.contributor.author | Kissling, Esther | |
| dc.contributor.author | on behalf of theEuropean primary care VE group | |
| dc.date.accessioned | 2026-03-03T10:03:08Z | |
| dc.date.available | 2026-03-03T10:03:08Z | |
| dc.date.issued | 2024-07-08 | none |
| dc.identifier.other | 10.1016/j.vaccine.2024.06.056 | |
| dc.identifier.uri | http://edoc.rki.de/176904/13467 | |
| dc.language.iso | eng | none |
| dc.publisher | Robert Koch-Institut | |
| dc.rights | (CC BY 3.0 DE) Namensnennung 3.0 Deutschland | ger |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/de/ | |
| dc.subject.ddc | 610 Medizin und Gesundheit | none |
| dc.title | Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)] | none |
| dc.type | article | |
| dc.identifier.urn | urn:nbn:de:0257-176904/13467-6 | |
| dc.type.version | publishedVersion | none |
| local.edoc.container-title | Vaccine | none |
| local.edoc.type-name | Zeitschriftenartikel | |
| local.edoc.container-type | periodical | |
| local.edoc.container-type-name | Zeitschrift | |
| local.edoc.container-publisher-name | Elsevier B.V. | none |
| local.edoc.container-reportyear | 2024 | none |
| local.edoc.container-firstpage | 1 | none |
| local.edoc.container-lastpage | 2 | none |
| dc.description.version | Peer Reviewed | none |
